12 mars 2009
Publication de la première
étude scientifique au monde sur l'utilisation de la thérapie
hyperbare basse pression pour les enfants affectés par
treatment for children with autism: a multicenter, randomized,
''Conclusions: Les enfants avec l'autisme
qui ont reçu 40 sessions d'une heure du traitement hyperbare
à 1.3 atm et 24% d'oxygène ont eu des améliorations
significatives dans le fonctionnement global, la réceptivité
au langage, l'interaction sociale, le contact visuel et la conscience
sensorielle comparativement aux enfants qui ont reçu de
l'air ambiant (21%) légèrement pressurisé
(1.03 atm).''Par Dr Daniel
Rossignol et Collègues
l'étude dans les nouvelles:
Autisme: l'oxygène hyperbare pourrait être
efficace selon une étude
Hyperbaric therapy shows promise for autism treatment
Can hyperbaric oxygen therapy help autistic kids?
Hyperbaric Therapy Called Effective Against Autism
Hyperbaric treatment for autism reports significant
Réactions aux critiques
négatives de l'étude:
15 mars 2009
The conflicts of researcher Dr. Daniel Rossignal are mentioned
by Maugh, "Critics also note that Rossignal is one of the
biggest promoters of hyperbaric oxygen therapy for autistic children
and has staked his career on obtaining positive results. The
study was funded by manufacturers of the devices, who also have
a vested interest."
Many of us in the autism community have spent years reading about
Dr. Paul Offit vouching for vaccines. Usually he's described
as "head of infectious diseases, Children's Hospital of
Philadelphia," and only occasionally as the developer of
the rotavirus vaccine. The contrast is glaring....NEVER IS IT
NOTED that having been a member of ACIP and as a vaccine patent
holder, Offit "has staked his career" on the claim
that vaccines don't cause autism.
Media editor: Age of Autism
+ + + +
"Physicians, moreover, do
not see a biological rationale for why the therapy should work."
Which physicians did you ask about
this? Maybe the paper below and others that are following this
effect will help lead us to the explanation:
1: Am J Physiol Heart Circ Physiol.
2006 Apr;290(4):H1378-86. Epub 2005 Nov 18.
Stem cell mobilization by hyperbaric oxygen.
Thom SR, Bhopale VM, Velazquez
OC, Goldstein LJ, Thom LH, Buerk DG.
Institute for Environmental Medicine,
University of Pennsylvania, Philadelphia,
PA 19104-6068, USA. firstname.lastname@example.org
Ted Fogarty, MD
+ + + +
HBOT for brain-injured children
is now covered by Medicaid in about 20 states due to legal action
taken by aggressive parents of cerebral palsy children. Like
autism, CP is an hypoxic-ischemic brain-injury. All of the FDA-approved
uses for HBOT are for the treatment of hypoxic-ischemic tissue
where hypoxic is lack of oxygen and ischemic is lack of circulation--which
creates hypoxia. Virtually 100% of everything prescribed for
brain-injured children is not only off-label but so far off-label
that nothing prescribed is FDA-approved for pediatric use--which
means the standard of medical practice for cerebral
palsy and autistic children is the prescribing of medications
that are not FDA-approved for pediatric use. Therefore the off-label
use of HBOT for CP/autism is actually just the standard of medical
practice for these conditions; however, the hypocritical pediatric
neurology community demands a higher level of "proof"
of efficacy before insurance coverage is possible. The Rossignol
study is far, far more of a proof of efficacy than the pediatric
neurology community has ever produced for any of the drugs now
prescribed to these children. See MedicaidforHBOT dot com for